ARAY ACCURAY INC

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business model: Development and sale of advanced radiation therapy systems including CyberKnife robotic radiosurgery and TomoTherapy helical radiation platforms
• • New product emphasis: Introduction of Accuray Helix CT-guided helical radiotherapy system combining affordability and automation to expand radiation access
• • Strategic shift: Expanded international sales focus with new direct offices and distributors plus key collaborations including 2024 AI radiotherapy system performance prediction with Airbus
• • Quantitative highlight: CyberKnife S7 System enables treatment plans up to 90% faster and treatments up to 50% faster, enhancing clinical efficiency
• • Noteworthy fact: 2025 filing highlights novel AI-driven real-time tumor tracking tech (Synchrony) integrated with motion-adaptive treatment delivery as a market differentiator

Risk Factors

• • Regulatory risk from FDA and other clearances, critical for product sales and R&D costs impacting future capital needs
• • Macroeconomic exposure to China anti-corruption campaign and stimulus timing, affecting operations and liquidity forecasts
• • Supply chain cost inflation raised inventory costs by $9.1 million, pressuring gross margins through 2025
• • Convertible Notes refinancing risk with $18 million principal still due June 2026, backed by $20 million delayed draw facility
• • Competitive threat from evolving technologies impacting the demand forecast assumptions used in inventory valuation and reserves

Management Discussion & Analysis

• • Revenue impact negative from U.S. reduced budgets and longer installations, continuing through FY2026, no specific revenue $ reported
• • Gross margin and net income adversely affected by inflation, supply chain, freight costs; impact expected through at least calendar year 2025, no margin % given
• • Approximately 70% raw materials U.S.-sourced; 80%+ products exported; tariff uncertainties may reduce sales to China through H1 FY2026
• • No fiscal 2025 bonuses paid to comply with debt covenants and conserve cash amid uncertain macroeconomic environment
• • Management monitoring liquidity, customer and supplier actions, evaluating operating expenses and real estate usage for cost control

What are the latest ARAY SEC filings in 2026?

ACCURAY INC (ARAY) has filed a 10-K annual report on August 28, 2025, a 10-Q quarterly report on May 6, 2026, an 8-K current report on August 6, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did ARAY file its most recent 10-K annual report?

ACCURAY INC (ARAY) filed its most recent 10-K annual report on August 28, 2025. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view ARAY 10-Q quarterly reports?

ACCURAY INC (ARAY)'s most recent 10-Q quarterly report was filed on May 6, 2026. SignalX displays every ARAY 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has ARAY filed recently?

ACCURAY INC (ARAY)'s most recent 8-K was filed on August 6, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find ARAY insider trading activity (Form 4)?

SignalX aggregates every ARAY Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does ARAY file with the SEC?

ACCURAY INC (ARAY) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ARAY filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for ACCURAY INC (ARAY).

What is ARAY's SEC CIK number?

ACCURAY INC (ARAY)'s SEC CIK (Central Index Key) number is 1138723. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1138723 to look up all ARAY filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find ARAY return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from ACCURAY INC (ARAY) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.